Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 29.

Journal Article

Bischoff, M., Glossmann, J., Skoetz, N., Starbatty, B. and Farin-Glattacker, E. (2018). Impact of a central coordination service for standard operating procedures (SOPs)- Evaluation of a national cooperation of oncological centers of excellence of the German Cancer Aid. Oncol. Res. Treat., 41. S. 20 - 21. BASEL: KARGER. ISSN 2296-5262

Ernst, M., Skoetz, N., Aldin, A., Goldkuhle, M., Monsef, I., Simon, S. T., Loeser, J., Moja, L., Forte, G. and Piechotta, V. (2020). Tramadol compared to placebo, and scheduled and non-scheduled opioid alternatives for the management of chronic malignant pain in adults and children: A systematic review. Oncol. Res. Treat., 43 (SUPPL 4). S. 244 - 245. BASEL: KARGER. ISSN 2296-5262

Folkerts, A. K., Ernst, M., Roheger, M., Liebermann-Jordanidis, H., Krohm, F., Droz, M., Adams, A., Eggers, C., Monsef, I., Dresen, A., Skoetz, N. and Kalbe, E. (2020). Clustering physical interventions for patients with Parkinson's disease in network meta-analyses. Mov. Disord., 35. S. S543 - 2. HOBOKEN: WILEY. ISSN 1531-8257

Glossmann, J-P, Scheid, C., Engelhardt, M., Goldschmidt, H., Einsele, H., Starbatty, B., Bischoff, M., Follmann, M. and Skoetz, N. (2017). NEW CLINICAL PATHWAYS OF THE CENTERS OF EXCELLENCE NETWORK IN GERMANY: A NEW CONCEPT FOR STANDARDIZED CARE OF MULTIPLE MYELOMA PATIENTS. Haematologica, 102. S. 512 - 514. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Glossmann, J. -P, Starbatty, B., Bischoff, M., Follmann, M. and Skoetz, N. (2016). Recommendations for diagnosis, treatment and follow-up in oncology - an inventory of Standard Operating Procedures (SOPs) of centers of excellence. Oncol. Res. Treat., 39. S. 43 - 45. BASEL: KARGER. ISSN 2296-5262

Glossmann, Jan-P., Follmann, M., Starbatty, B., Bischoff, M., Jakob, T. and Skoetz, N. (2018). Network SOP meet oncological guidelines: Standardized algorithms for diagnosis, therapy and follow-up of cancer patients. Oncol. Res. Treat., 41. S. 121 - 122. BASEL: KARGER. ISSN 2296-5262

Hartmann, T., Huebel, K., Monsef, I, Engert, A. and Skoetz, N. (2015). Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for malignant lymphoma or multiple myeloma patients: A systematic review with meta-analysis. Oncol. Res. Treat., 38. S. 71 - 72. BASEL: KARGER. ISSN 2296-5262

Hutzschenreuter, F., Kreuzer, K. -A, Monsef, L., Engert, A. and Skoetz, N. (2015). Granulocyte and granulocyte-macrophage colony stimulating factors for patients with myelodysplastic syndromes: systematic review with meta-analysis. Oncol. Res. Treat., 38. S. 184 - 186. BASEL: KARGER. ISSN 2296-5262

Jakob, T., Follmann, M., Borchmann, P., Baues, C., Sasse, S., Broeckelmann, P. J., Kreissl, S., Eichenauer, D., von Tresckow, B., Buerkle, C., Engert, A. and Skoetz, N. (2018). Guideline update on diagnosis, therapy and follow-up of adult Hodgkin lymphoma patients. Oncol. Res. Treat., 41. S. 17 - 18. BASEL: KARGER. ISSN 2296-5262

Koehler, N., Jordan, K., Jahn, F., Woermann, B. and Skoetz, N. (2016). Bisphosphonates or RANK-ligand inhibitors for patients with solid cancer and bone metastases or multiple myeloma: a systematic Cochrane review and meta-analysis. Oncol. Res. Treat., 39. S. 164 - 165. BASEL: KARGER. ISSN 2296-5262

Krebs, S., Starbatty, B., Skoetz, N., Schmidt-Wolf, I, Brandts, C., Bischoff, M., Wolf, J. and Glossmann, J. P. (2016). Use of local oncological Standard Operating Procedures (SOPs) and oncological guidelines: A survey of 1600 physicians at 4 oncology sites/centers of excellence. Oncol. Res. Treat., 39. S. 41 - 43. BASEL: KARGER. ISSN 2296-5262

Kuhr, K., Scheckel, B., Haque, M., Weigl, A., Monsef, I, Bohlius, J. and Skoetz, N. (2018). Intravenous versus oral versus no iron with or without erythropoiesisstimulating agents (ESA) for anaemic cancer patients: A systematic review and network meta-analysis. Oncol. Res. Treat., 41. S. 215 - 217. BASEL: KARGER. ISSN 2296-5262

Macherey, S., Jahn, F., Jordan, K. and Skoetz, N. (2016). Bisphosphonates for patients with bone metastases from prostate cancer. A Cochrane review update including more than 5,000 patients. Oncol. Res. Treat., 39. S. 22 - 24. BASEL: KARGER. ISSN 2296-5262

Piechotta, V, John, L., Jung, J., Graziani, G., Reinhardt, H., Holtick, U., Semrau, R., Trog, D., Voelker, L. A., Herling, M., Fend, F., Harder, L., Weinhold, N., Kriegsmann, K., Merz, M., Delorme, S., Derlin, T., Raab, M. S., Goede, V, Schubert, M., Hohloch, K., Senf, B., Simon, S. T., Baumann, W., Fetscher, S., Schinke, M., Holtkamp, U., Einsele, H., Engelhardt, M., Goldschmidt, H., Scheid, C. and Skoetz, N. (2020). Interdisciplinary guideline on diagnosis, therapy, and follow-up of adult patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Oncol. Res. Treat., 43 (SUPPL 4). S. 96 - 97. BASEL: KARGER. ISSN 2296-5262

Rancea, M., Skoetz, N., Trelle, S., da Costa, B. R., Engert, A., Fischer, K., Hallek, M. and Eichhorst, B. (2014). FIRST-LINE TREATMENT STRATEGIES FOR PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA: PRELIMINARY RESULTS OF A NETWORK META-ANALYSIS. Haematologica, 99. S. 58 - 59. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Rancea, M., von Tresckow, B., Monsef, I, Engert, A. and Skoetz, N. (2014). The role of high-dose chemotherapy followed by autologous stem cell transplantation in patients with relapsed/refractory Hodgkin lymphoma: a systematic review with meta-analysis. Oncol. Res. Treat., 37. S. 147 - 148. BASEL: KARGER. ISSN 2296-5262

Scheid, C., Engelhardt, M., Goldschmidt, H., Einsele, H., Starbatty, B., Bischoff, M., Glossmann, J-P and Skoetz, N. (2016). Standard Operating Procedures (SOPs) of centers of excellence for the diagnosis, treatment and follow-up of multiple myeloma patients: similarities and differences. Oncol. Res. Treat., 39. S. 68 - 69. BASEL: KARGER. ISSN 2296-5262

Sickinger, M. T., von Tresckow, B., Kobe, C., Engert, A., Borchmann, P. and Skoetz, N. (2014). PET-ADAPTED TREATMENT MODIFICATION IN EARLY STAGE HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. Haematologica, 99. S. 399 - 400. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Skoetz, N., Bergenthal, N., Will, A., Streckmann, F., Elter, T. and Engert, A. (2014). Physical exercise improves fatigue in patients with haematological malignancies: a Cochrane systematic review and meta-analysis. Oncol. Res. Treat., 37. S. 277 - 278. BASEL: KARGER. ISSN 2296-5262

Skoetz, N., Bergenthal, N., Will, A., Streckmann, F., Monsef, I., Wolkewitz, K. D., Elter, T. and Engert, A. (2014). AEROBIC PHYSICAL EXERCISE FOR PATIENTS WITH HAEMTOLOGICAL MALIGNANCIES. A SYSTEMATIC REVIEW AND META-ANALYSIS. Haematologica, 99. S. 517 - 518. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Skoetz, N., Blank, O., Buetikofer, L., Monsef, I., Engert, A. and Vehreschild, J. J. (2016). ANTIBIOTICS VERSUS G-CSFS VERSUS A COMBINATION OF BOTH TO PREVENT INFECTIOUS COMPLICATIONS AND DEATHS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: PRELIMINARY RESULTS OF A NETWORK META-ANALYSIS. Haematologica, 101. S. 484 - 486. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Skoetz, N., Haque, M., Monsef, I, Jordan, K., Kuhr, K. and Scheckel, B. (2018). Antiemetics for highly emetogenic chemotherapy: A systematic review and network meta-analysis. Oncol. Res. Treat., 41. S. 212 - 214. BASEL: KARGER. ISSN 2296-5262

Skoetz, N., Rancea, M., Trelle, S., Nueesch, E., Engert, A. and Kreuzer, K. A. (2015). COMPARISON OF TYROSINE-KINASE INHIBITORS AS FIRST-LINE TREATMENT FOR CHRONIC MYELOID LEUKEMIA: RESULTS OF A NETWORK META-ANALYSIS INCLUDING 6314 PATIENTS. Haematologica, 100. S. 433 - 434. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Starbatty, B., Skoetz, N., Bischoff, M. and Glossmann, J. -P. (2018). Importance and diversity of center-specific oncological SOPs: Development of a Manual to harmonize SOPs within the Network of Centers of Excellence. Oncol. Res. Treat., 41. S. 123 - 125. BASEL: KARGER. ISSN 2296-5262

Tesfamariam, Y., Jakob, T., Woeckel, A., Adams, A., Weigl, A., Monsef, I., Kuhr, K. and Skoetz, N. (2019). Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis. Crit. Rev. Oncol./Hematol., 137. S. 1 - 9. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461

Tesfamariam, Y. M., Jakob, T., Macherey, S., Monsef, I, Heidenreich, A., Becker, I, Kuhr, K. and Skoetz, N. (2018). Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: A Cochrane review and network meta-analysis. Oncol. Res. Treat., 41. S. 326 - 327. BASEL: KARGER. ISSN 2296-5262

Tesfamariam, Y. M., Jakob, T., Woeckel, A., Monsef, I., Kuhr, K. and Skoetz, N. (2018). Adjuvant bisphosphonates or RANK-ligand-inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis. Oncol. Res. Treat., 41. S. 160 - 161. BASEL: KARGER. ISSN 2296-5262

Weigl, A., Koehler, N., Monsef, I., Bohlius, J., Becker, I., Kuhr, K. and Skoetz, N. (2017). INTRAVENOUS IRON VERSUS ORAL IRON VERSUS NO IRON WITH OR WITHOUT ERYTHROPOIESISSTIMULATING AGENTS FOR CANCER PATIENTS WITH ANAEMIA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS. Haematologica, 102. S. 334 - 335. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Will, A., Monsef, I, Woeckel, A. and Skoetz, N. (2016). Mindfulness-based stress reduction for women diagnosed with breast cancer: A systematic review and meta-analysis. Oncol. Res. Treat., 39. S. 179 - 180. BASEL: KARGER. ISSN 2296-5262

This list was generated on Fri Mar 29 07:28:37 2024 CET.